Behavioral Diagnostics Awarded Grant to Commercialize a Precision Medicine Test for Guiding Smoking Therapy
August 2016: Behavioral Diagnostics (BD) LLC is pleased to announce that the National Institutes of Health has awarded it the first installment of a $900,000 project to develop a quantitative test for smoking that uses saliva DNA.
LEARN MOREBehavioral Diagnostics Awarded Grant to Commercialize Epigenetic Alcohol Test
May 2016: Behavioral Diagnostics Inc. (BDI) is pleased to announce that the National Institutes of Health has awarded it a $1.4 million grant to complete the initial commercialization of an epigenetic test for the detection of heavy alcohol consumption.
LEARN MORE